MedTrace Logo

A Prospective Cohort of Children With HIV Infection

NCT00476606 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2025-03-17

No results posted yet for this study

Summary

To evaluate clinical and immunological outcome of children treated with HAART.

Conditions

  • HIV Infections

Interventions

DRUG

Zidovudine, Stavudine, Didanosine, Lamivudine

Refer to the Thai guideline for HIV management 2007

DRUG

Nevirapine, Efavirenz

Refer to the Thai guideline for HIV management 2007

DRUG

LPV/r, Saquinavir, Indinavir, Ritonavir, Nelfinavir

Refer to the Thai guideline for HIV management 2007

Sponsors & Collaborators

  • Khon Kaen University

    collaborator OTHER

  • The HIV Netherlands Australia Thailand Research Collaboration

    lead OTHER

Principal Investigators

  • Kiat Ruxrungtham, MD, MSc · HIV-NAT, The Thai Red Cross AIDS Research Centre

Eligibility

Min Age
1 Day
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-03-31
Primary Completion
2024-09-12
Completion
2024-09-12

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00476606 on ClinicalTrials.gov